Please store the product under the recommended conditions in the Certificate of Analysis.
产品详情
Ipilimumab 是一种全人类单克隆抗体 IgG1κ,可阻断 T 细胞上的抑制性受体细胞毒性 T 淋巴细胞抗原4(CTLA-4)。Ipilimumab 可用于不可切除或转移性黑色素瘤(MM)研究。
生物活性
Ipilimumab is a fully human monoclonal antibody IgG1κ that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab can be used in unresectable or metastatic melanoma (MM) studies.
性状
Liquid
体外研究(In Vitro)
Ipilimumab 抑制 CTLA-4,使 T 细胞免疫反应对肿瘤细胞重新激活。Ipilimumab 可作为单剂或与细胞因子、化疗或疫苗联合使用,促进抗肿瘤活性。Ipilimumab (0,5 or 50 μg/ mL, 6 days) 单独使用可增强 IL-2 的产生,与 nivolumab 联合使用可刺激外周血单核细胞(PBMC)中更高的 IL-2 释放。而 ipilimumab 和 nivolumab 联合治疗可协同增强效应性和记忆性 T 细胞反应。 has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Ipilimumab(静脉注射,3 或10mg/kg,每周一次,持续 4 周)联合 nivolumab(10 或 50mg/kg)导致食蟹猴的胃肠道炎症,并与白蛋白减少、球蛋白增加、中性粒细胞和嗜酸性粒细胞计数增加以及大肠单核炎症有关。高剂量组表现为反复腹泻,其胰腺中的腺泡细胞也有明显的脱颗粒现象。 has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
ClinicalTrial
参考文献
[1]. Movva S, et al. The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management. Expert Opin Biol Ther. 2009 Feb;9(2):231-41.[2]. Mark J Selby, et al. Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology. PLoS One. 2016 Sep 9;11(9):e0161779.